Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Appointed director
GeoVax Labs, Inc. (GOVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update"
05/05/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update"
03/24/2023 8-K Quarterly results
Docs: "GeoVax Reports 2022 Year-End Financial Results And Provides Corporate Update"
11/14/2022 8-K Quarterly results
Docs: "GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
08/04/2022 8-K Quarterly results
Docs: "FINANCIAL TABLES FOLLOW MORE GEOVAX LABS, INC. Condensed Consolidated Statements of Operations Information",
"Conference Call Transcript",
"Conference Call Slide Presentation"
05/02/2022 8-K Quarterly results
Docs: "GeoVax Reports 2022 First Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
03/10/2022 8-K Quarterly results
Docs: "GeoVax Reports 2021 Year-End Financial Results And Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
11/12/2021 8-K Quarterly results
Docs: "GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
05/07/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
Docs: "GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update"
11/05/2020 8-K Quarterly results
Docs: "GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update"
08/10/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
03/25/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update"
08/14/2019 8-K Quarterly results
Docs: "GeoVax Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress"
05/14/2019 8-K Quarterly results
Docs: "GeoVax Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress ATLANTA, GA, May 14, 2019 – GeoVax Labs, Inc. , a biotechnology company developing human vaccines, today announced its financial results for the three months ended March 31, 2019 and provided an update on its corporate development progress. David A. Dodd, GeoVax’ s President and CEO, commented, “To date during 2019, we continue to make progress in several of our key focus areas despite the limited capital resources which have constrained our activities. Nonetheless, through the efforts of our dedicated staff here are a few recent examples of our collaboration and funding achievements: - Cancer Immunotherapy – We continued our work with Leidos, Inc. under our collaboration to evaluate delivery ..."
03/27/2019 8-K Quarterly results
Docs: "GeoVax Reports 2018 Year-End Financial Results ATLANTA, GA, March 27, 2019 – GeoVax Labs, Inc. , a biotechnology company developing human vaccines, today announced its financial results for the year ended December 31, 2018. GeoVax reported a net loss for the year ended December 31, 2018 of $2.6 million, or $0.02 per share, based on 163.6 million weighted average shares outstanding. For the year ended December 31, 2017, the Company reported a loss of $2.2 million, or $0.03 per share, based on 68.6 million weighted average shares outstanding. Grant and collaboration revenues of $1.0 million for 2018, as compared to $1.1 million in 2017. Research and development expenses were $1.9 million in 2018, compared with $2.0 million in 2017. General and administrative expenses were $1.6 million in 201..."
11/09/2018 8-K Quarterly results
Docs: "GeoVax Reports 2018 Third Quarter Financial Results and Provides Corporate Update"
08/07/2018 8-K Quarterly results
Docs: "GeoVax Reports 2018 Second Quarter Financial Results and Provides Corporate Update"
05/03/2018 8-K Quarterly results
Docs: "GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates"
03/23/2018 8-K Quarterly results
Docs: "GeoVax Reports 2017 Year-End Financial Results ATLANTA, GA, March 23, 2018 – GeoVax Labs, Inc. , a biotechnology company developing innovative human vaccines using its novel platform technology, today announced its financial results for the year ended December 31, 2017. GeoVax reported grant and collaboration revenues of $1.1 million for 2017, as compared to $0.8 million in 2016. Research and development expenses were $2.0 million in 2017, compared with $2.0 million in 2016. General and administrative expenses were $1.2 million in 2017, compared to $2.1 million in 2016. Net loss for the year ended December 31, 2017 of $2.2 million, or $0.03 per share, based on 68.6 million weighted average shares outstanding. For the year ended December 31, 2016, the Company reported a loss of $3.3 million..."
11/09/2017 8-K Quarterly results
Docs: "GeoVax Reports 2017 Third Quarter Financial Results and Development Program Updates"
08/07/2017 8-K Quarterly results
05/08/2017 8-K Form 8-K - Current report
03/24/2017 8-K Form 8-K - Current report
11/14/2016 8-K Quarterly results
Docs: "GeoVax Reports 2016 Third Quarter Financial Results and Provides Corporate Update"
08/05/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
03/17/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "GeoVax Reports 2015 Third Quarter Financial Results"
08/05/2015 8-K Quarterly results
Docs: "GeoVax Reports 2015 Second Quarter Financial Results and Provides Corporate Update"
05/14/2015 8-K Quarterly results
Docs: "Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs, Inc",
"GeoVax Reports 2015 First Quarter Financial Results And Provides Corporate Update"
03/20/2015 8-K Quarterly results
Docs: "GeoVax Reports 2014 Year-End Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy